Preparation and metabolism of a cisplatin/serum protein complex.
暂无分享,去创建一个
[1] L. Sternson,et al. Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma. , 1977, Clinical chemistry.
[2] H. Schatz,et al. [51Cr]Albumin. Biochemical and metabolic studies. , 1968, Clinica chimica acta; international journal of clinical chemistry.
[3] C. Desaive,et al. Effects of antimitotic agents bound to a macromolecular carrier in normal or cancer cells. Importance of the mode of binding of the agent to the carrier. , 1978, European journal of cancer.
[4] M. Friedman,et al. Protection of the active site of mitochondrial malate dehydrogenase from inhibition by potassium tetrachloroplatinate. , 1975, Biochimica et biophysica acta.
[5] W. Wolf,et al. Distribution of cis-platin in blood. , 1978, Chemico-biological interactions.
[6] B. Benacerraf,et al. Phagocytosis of heat-denatured human serum albumin labelled with 131I and its use as a means of investigating liver blood flow. , 1957, British journal of experimental pathology.
[7] H. Tarver,et al. Plasma protein. I. Loss from circulation and catabolism to carbon dioxide. , 1951, The Journal of biological chemistry.
[8] K. Sterling. The turnover rate of serum albumin in man as measured by I131-tagged albumin. , 1951, The Journal of clinical investigation.
[9] F. Putnam. 2 – Alpha, Beta, Gamma, Omega — The Roster of the Plasma Proteins , 1975 .
[10] Howard M. Rawnsley,et al. Clinical biochemical and hematological reference values in normal experimental animals , 1977 .